Floatz logo

MACROGOLS

Inflammatory Bowel Disease

Region SkanemixturePhase 4 / ApprovedActive
A
81/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
72/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Inflammatory Bowel Disease cohort.

Asset / SponsorPhaseRating
Prucalopride
Region Skane
Phase 4BBB
Marcaine
Cedars-Sinai Medical Center
Phase 4BBB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB
Dexasone
Cedars-Sinai Medical Center
Phase 4BB
SODIUM PHOSPHATE
Region Skane
Phase 3BB

View all 31 →

Same molecule, other indications

MACROGOLS is also rated in:

polyp of colonActive
BBB
Indicative · Phase 4
75 / 100
View asset →
intestinal cancerDormant
BB
Indicative · Phase 4
69 / 100
View asset →
celiac diseaseDormant
BB
Indicative · Phase 4
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →